Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ICON Public Limited Company    ICLR   IE0005711209

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/24/2020 11/25/2020 11/27/2020 11/30/2020 12/01/2020 Date
186.37(c) 188.25(c) 191.14(c) 194.88(c) 198.72 Last
244 997 130 447 49 187 170 766 99 711 Volume
-0.77% +1.01% +1.54% +1.96% +1.97% Change
More quotes
Financials (USD)
Sales 2020 2 791 M - -
Net income 2020 330 M - -
Net cash position 2020 306 M - -
P/E ratio 2020 31,6x
Yield 2020 -
Sales 2021 3 139 M - -
Net income 2021 423 M - -
Net cash position 2021 526 M - -
P/E ratio 2021 24,4x
Yield 2021 -
Capitalization 10 285 M 10 285 M -
EV / Sales 2020 3,58x
EV / Sales 2021 3,11x
Nbr of Employees 15 250
Free-Float 98,5%
More Financials
Company
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its... 
Sector
Biotechnology & Medical Research
Calendar
12/02 | 05:20pmPräsentation
More about the company
Notations Surperformance© of ICON Public Limited Company
Trading Rating : Investor Rating :
More Ratings
All news about ICON PUBLIC LIMITED COMPANY
11/11ICON PUBLIC : Releases First Environmental, Social and Governance Report
BU
10/30ICON PLC : to Present at the 29th Annual Credit Suisse Virtual Healthcare Confer..
BU
10/21ICON PUBLIC : plc Q3 2020 Presentation
PU
10/21ICON PUBLIC : Reports Third Quarter 2020 Results
BU
10/19ICON PUBLIC : BARDA reselects ICON as preferred partner to help strengthen US em..
BU
10/07ICON PUBLIC : Wins Best CRO at the Vaccine Industry Excellence Awards
BU
09/03ICON : Launches Accellacare a Global Clinical Research Network Focused on Increa..
BU
09/02ICON PLC : to Present at Wells Fargo 2020 Virtual Global Healthcare Conference a..
BU
08/21ICON PUBLIC : Forbes names ICON in list of Best Employers in America for Women
BU
07/22ICON PUBLIC : plc Q2 2020 Presentation
PU
07/22ICON PUBLIC : Shareholders Vote in Favour of All Resolutions at its Annual Gener..
BU
07/22ICON PUBLIC : Reports Second Quarter 2020 Results
BU
05/27ICON PLC : to Present at Jefferies Virtual Healthcare Conference
BU
05/13ICON PLC : to Present at UBS Virtual Global Healthcare Conference
BU
05/05ICON PUBLIC : Appoints New Chief Medical Officer
BU
More news
News in other languages on ICON PUBLIC LIMITED COMPANY
02/14ICON PUBLIC LIMITED COMPANY : Veröffentlichung des Jahresergebnisses
02/14ICON PUBLIC LIMITED COMPANY : publication des résultats annuels
2019ICON PLC : Veröffentlichung des Jahresergebnisses
2019ICON PLC : publication des résultats annuels
2018ASIT BIOTECH : réunit les investigateurs pour une étude
More news
Chart ICON PUBLIC LIMITED COMPANY
Duration : Period :
ICON Public Limited Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICON PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 207,20 $
Last Close Price 194,88 $
Spread / Highest target 23,2%
Spread / Average Target 6,32%
Spread / Lowest Target -22,0%
EPS Revisions
Managers
NameTitle
Stephen A. Cutler Chief Executive Officer & Executive Director
Ciaran Murray Executive Chairman
Brendan Brennan Chief Financial Officer
Tom O'Leary Chief Information Officer
Anthony J. Japour Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
ICON PUBLIC LIMITED COMPANY13.15%10 285
MODERNA, INC.680.88%60 441
LONZA GROUP AG61.27%46 692
CELLTRION, INC.82.04%41 055
IQVIA HOLDINGS INC.9.37%32 400
SEAGEN INC.49.05%30 708